Download presentation
Presentation is loading. Please wait.
Published byMarie Marie-Noëlle Dubois Modified over 6 years ago
1
RBWH ICU JOURNAL CLUB NOVEMBER 2014
3
Summary Questions asked Jistorical background Trial design Patients
Results Discussion
4
Questions asked Does higher Hb threshold improve neurological outcome
Does EPO do more than just estimulate the bone marrow
5
Evolution Silver, CCM 2006; EPO decreases the need for RBC transfusions in critically ill Corwin, NEJM 2007; More VTE but maybe improved mortality in trauma Napolitano, JTrauma, 2008; IU EPO improves mortality by 50% at 29 days(n=2760) EAST, CCM, 2009; Level 2 recommendation on EPO administration in general trauma Desjardins, CC, A Systematic Review (n=4100) could not find a difference in Hb threshold and outcomes in TBI
6
EPO upregulates antiapoptosis messenger in brain (and spine)
J Exp Med. Sep 15, 2003; 198(6): 971–975. doi: /jem
8
What about Hb thresholds?
9
Trial design Multiple level 1 or 2 trauma centres in Houston
2X2 design Enrolment within 6 hours from injury EPO or no EPO Transfusion thresholds 7 or 10g/dL Blinded for EPO but not for Hb threshold Power of study changed with EPO dosing
10
500IU $1.35/100IU
13
Patients N= 200; x4 groups but in reality x6
Closed head injury with GCS>3 Changed EPO dosing Blinding for EPO
15
Outcomes Glasgow outcome score Mortality Respiratory failure
Infections EPO levels
16
Results No difference in outcome scores with either intervention
Perhaps more VTE’s in the high Hb group
19
Discussion EPO costs money and probably gives no benefit
Blood costs money Blood is a scarce resource and could cause harm NOT giving blood in hemodyanmic stable non bleeding patients is safe
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.